semaglutide and eye damage A new study suggests patients taking — the active ingredient in Ozempic Wegovy — Semaglutide Tied to Increased Risk

Clinical trials have shown impressive results: people taking tirzepatide , alongside a reduced-calorie diet and increased physical activity, lost on average 15% to 22% of their body weight over about 72 weeks

Some individuals may experience mild side effects, like nausea or gastrointestinal discomfort

Bottom line: Combining these two nutrients creates a "recycling" effect that maximizes their ability to protect your cells from oxidative stress and environmental toxins

Before we talk about the association and connection between their use and the risk of thyroid cancer, lets take a step back and talk about some basics: What Are GLP-1 Agonists & Why Should You Care